380 related articles for article (PubMed ID: 28369094)
1. Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification.
Fang S; Tian H; Li X; Jin D; Li X; Kong J; Yang C; Yang X; Lu Y; Luo Y; Lin B; Niu W; Liu T
PLoS One; 2017; 12(4):e0175050. PubMed ID: 28369094
[TBL] [Abstract][Full Text] [Related]
2. Optofluidic device for the quantification of circulating tumor cells in breast cancer.
Pedrol E; Garcia-Algar M; Massons J; Nazarenus M; Guerrini L; Martínez J; Rodenas A; Fernandez-Carrascal A; Aguiló M; Estevez LG; Calvo I; Olano-Daza A; Garcia-Rico E; Díaz F; Alvarez-Puebla RA
Sci Rep; 2017 Jun; 7(1):3677. PubMed ID: 28623262
[TBL] [Abstract][Full Text] [Related]
3. Magnetic-Based Microfluidic Device for On-Chip Isolation and Detection of Tumor-Derived Exosomes.
Xu H; Liao C; Zuo P; Liu Z; Ye BC
Anal Chem; 2018 Nov; 90(22):13451-13458. PubMed ID: 30234974
[TBL] [Abstract][Full Text] [Related]
4. A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis.
Zhao Z; Yang Y; Zeng Y; He M
Lab Chip; 2016 Feb; 16(3):489-96. PubMed ID: 26645590
[TBL] [Abstract][Full Text] [Related]
5. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes.
Kanwar SS; Dunlay CJ; Simeone DM; Nagrath S
Lab Chip; 2014 Jun; 14(11):1891-900. PubMed ID: 24722878
[TBL] [Abstract][Full Text] [Related]
6. Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device.
Galletti G; Sung MS; Vahdat LT; Shah MA; Santana SM; Altavilla G; Kirby BJ; Giannakakou P
Lab Chip; 2014 Jan; 14(1):147-56. PubMed ID: 24202699
[TBL] [Abstract][Full Text] [Related]
7. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
[TBL] [Abstract][Full Text] [Related]
8. Analysis of circulating tumor cells from lung cancer patients with multiple biomarkers using high-performance size-based microfluidic chip.
Gao W; Yuan H; Jing F; Wu S; Zhou H; Mao H; Jin Q; Zhao J; Cong H; Jia C
Oncotarget; 2017 Feb; 8(8):12917-12928. PubMed ID: 28039472
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis.
Thege FI; Lannin TB; Saha TN; Tsai S; Kochman ML; Hollingsworth MA; Rhim AD; Kirby BJ
Lab Chip; 2014 May; 14(10):1775-84. PubMed ID: 24681997
[TBL] [Abstract][Full Text] [Related]
10. Microfluidic device for on-chip isolation and detection of circulating exosomes in blood of breast cancer patients.
Chen W; Li H; Su W; Qin J
Biomicrofluidics; 2019 Sep; 13(5):054113. PubMed ID: 31893011
[TBL] [Abstract][Full Text] [Related]
11. Molecular Detection and Analysis of Exosomes Using Surface-Enhanced Raman Scattering Gold Nanorods and a Miniaturized Device.
Kwizera EA; O'Connor R; Vinduska V; Williams M; Butch ER; Snyder SE; Chen X; Huang X
Theranostics; 2018; 8(10):2722-2738. PubMed ID: 29774071
[TBL] [Abstract][Full Text] [Related]
12. DNA fragment-assisted microfluidic chip for capture and release of circulating tumor cells.
Chen D; Wen J; Zeng S; Ma H
Electrophoresis; 2019 Nov; 40(21):2845-2852. PubMed ID: 31267582
[TBL] [Abstract][Full Text] [Related]
13. Spiral shape microfluidic channel for selective isolating of heterogenic circulating tumor cells.
Kwak B; Lee J; Lee J; Kim HS; Kang S; Lee Y
Biosens Bioelectron; 2018 Mar; 101():311-316. PubMed ID: 29055574
[TBL] [Abstract][Full Text] [Related]
14. Efficient exosome subpopulation isolation and proteomic profiling using a Sub-ExoProfile chip towards cancer diagnosis and treatment.
Wang Y; Wang S; Chen A; Wang R; Li L; Fang X
Analyst; 2022 Sep; 147(19):4237-4248. PubMed ID: 36062905
[TBL] [Abstract][Full Text] [Related]
15. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
Hyun KA; Lee TY; Lee SH; Jung HI
Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
[TBL] [Abstract][Full Text] [Related]
16. Construction of a cleavable linker chemistry-based
Zhou S; Li Z; Li Y; Wang X; Deng K
Anal Methods; 2023 Dec; 15(48):6738-6749. PubMed ID: 38054244
[TBL] [Abstract][Full Text] [Related]
17. Plasma exosome microRNAs are indicative of breast cancer.
Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
[TBL] [Abstract][Full Text] [Related]
18. Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology.
He M; Crow J; Roth M; Zeng Y; Godwin AK
Lab Chip; 2014 Oct; 14(19):3773-80. PubMed ID: 25099143
[TBL] [Abstract][Full Text] [Related]
19. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.
Rupp AK; Rupp C; Keller S; Brase JC; Ehehalt R; Fogel M; Moldenhauer G; Marmé F; Sültmann H; Altevogt P
Gynecol Oncol; 2011 Aug; 122(2):437-46. PubMed ID: 21601258
[TBL] [Abstract][Full Text] [Related]
20. A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells.
Kao KJ; Tai CH; Chang WH; Yeh TS; Chen TC; Lee GB
Biosens Bioelectron; 2015 Jul; 69():272-9. PubMed ID: 25770459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
